Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
REL | hg38_v1_chr2_+_60881553_60881619 | 0.30 | 1.0e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_89143133 Show fit | 11.55 |
ENST00000492167.1
|
immunoglobulin kappa variable 3-20 |
|
chr2_-_89010515 Show fit | 10.22 |
ENST00000493819.1
|
immunoglobulin kappa variable 1-9 |
|
chr2_-_89085787 Show fit | 9.77 |
ENST00000390252.2
|
immunoglobulin kappa variable 3-15 |
|
chr2_+_90038848 Show fit | 7.93 |
ENST00000390270.2
|
immunoglobulin kappa variable 3D-20 |
|
chr2_-_88947820 Show fit | 7.71 |
ENST00000496168.1
|
immunoglobulin kappa variable 1-5 |
|
chr2_+_90114838 Show fit | 7.62 |
ENST00000417279.3
|
immunoglobulin kappa variable 3D-15 |
|
chr22_+_22195753 Show fit | 6.75 |
ENST00000390285.4
|
immunoglobulin lambda variable 6-57 |
|
chr12_-_9760893 Show fit | 6.60 |
ENST00000228434.7
ENST00000536709.1 |
CD69 molecule |
|
chr6_+_137867241 Show fit | 6.20 |
ENST00000612899.5
ENST00000420009.5 |
TNF alpha induced protein 3 |
|
chr6_+_137867414 Show fit | 5.68 |
ENST00000237289.8
ENST00000433680.1 |
TNF alpha induced protein 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 45.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 19.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.8 | 14.2 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
3.3 | 13.1 | GO:0034148 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
0.7 | 12.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.3 | 12.1 | GO:0003094 | glomerular filtration(GO:0003094) |
0.3 | 10.7 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
1.0 | 8.7 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 7.9 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
2.6 | 7.8 | GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 59.9 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 22.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 22.6 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 13.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 13.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.4 | 13.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 12.5 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.5 | 12.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 12.2 | GO:0005882 | intermediate filament(GO:0005882) |
2.3 | 11.5 | GO:0071756 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 75.1 | GO:0003823 | antigen binding(GO:0003823) |
0.3 | 18.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.0 | 15.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
1.5 | 12.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 10.1 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 9.4 | GO:0045296 | cadherin binding(GO:0045296) |
1.1 | 8.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.9 | 7.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 7.7 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 7.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 25.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 20.8 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 20.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 12.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 11.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 8.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 8.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 6.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 6.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 6.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 26.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 20.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.4 | 12.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 12.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 10.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.3 | 7.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 7.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 6.5 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 6.4 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 5.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |